-
sulfuric acid methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate
-
ChemBase ID:
44451
-
Molecular Formular:
C16H18ClNO6S2
-
Molecular Mass:
419.90022
-
Monoisotopic Mass:
419.02640698
-
SMILES and InChIs
SMILES:
C1CN(Cc2c1scc2)[C@@H](c1c(cccc1)Cl)C(=O)OC.S(=O)(=O)(O)O
Canonical SMILES:
OS(=O)(=O)O.COC(=O)[C@H](c1ccccc1Cl)N1CCc2c(C1)ccs2
InChI:
InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1
InChIKey:
FDEODCTUSIWGLK-RSAXXLAASA-N
-
Cite this record
CBID:44451 http://www.chembase.cn/molecule-44451.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
sulfuric acid methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate
|
|
|
|
|
IUPAC Traditional name
|
|
clopidogrel; sulfuric acid
|
|
|
|
|
Synonyms
|
|
(S)-(+)-Clopidogrel bisulfate
|
|
(S)-(+)-Methyl 2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate hydrogensulfate
|
|
Clopidogrel Bisulphate
|
|
(S)-(+)-Clopidogrel hydrogensulfate
|
|
(S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate
|
|
Clopidogrel bisulfate
|
|
sulfuric acid methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate
|
|
Clopidogrel Hemisulfate
|
|
Iscover
|
|
Myogrel
|
|
Plavix
|
|
(S)-(+)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate
|
|
Clopidogrel Bisulfate
|
|
SR 25990C
|
|
Stroka
|
|
S-(+)-Clopidogrel Hydrogen Sulfate
|
|
|
|
|
CAS Number
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
H Acceptors
|
2
|
H Donor
|
0
|
LogD (pH = 5.5)
|
3.875259
|
LogD (pH = 7.4)
|
4.029398
|
Log P
|
4.031764
|
Molar Refractivity
|
84.927 cm3
|
Polarizability
|
32.98264 Å3
|
Polar Surface Area
|
29.54 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Selleck Chemicals
Sigma Aldrich
TRC
Selleck Chemicals -
S1415
|
Research Area: Cardiovascular Disease Biological Activity: Clopidogrel (Plavix) is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Clopidogrel works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate ADP chemoreceptor. [1] |
Sigma Aldrich -
SML0004
|
Biochem/physiol Actions (S)-(+)-Clopidogrel hydrogen sulfate is an antithrombotic antiplatelet agent. It specifically and irreversibly inhibits the Purinoceptor P2Y12 subtype which inhibits ADP-induced platelet aggregation. (S)-(+)-Clopidogrel hydrogen sulfate is the active isomer. |
PATENTS
PATENTS
PubChem Patent
Google Patent